| Old Articles: <Older 26331-26340 Newer> |
|---|
 |
The Motley Fool
September 27, 2007
Rich Smith |
Lockheed's Pathetic Perks Lockheed Martin offers a discount on the 2008 The Year in Space calendar to stockholders, and just about everyone else.   |
The Motley Fool
September 27, 2007
Tom Taulli |
NetScout Scoops Up Network General The network technology company NetScout is trying to boost its prospects with a major acquisition of Network General, but integrating the new company will demand a lot of time and resources. Investors, take note. |
The Motley Fool
September 27, 2007
Anders Bylund |
Bed Bath & Beyond Pays Cash for Growth: Fool by Numbers The fast facts about Bed Bath & Beyond. Second quarter earnings reports show that the home furnishings retailer remains debt-free, but growth is slowing and margins are lower. |
The Motley Fool
September 26, 2007
Mac Greer |
Fool Video: A Halo Effect for Microsoft and Video Game Stocks? Will Microsoft's Halo 3 produce heavenly returns for investors? What does its release mean for video game makers such as Activision and Electronic Arts? Will there be a halo effect for Wal-Mart and other retailers? These questions are discussed in this video. |
The Motley Fool
September 26, 2007
David Lee Smith |
Shelling Out for More Refinement Royal Dutch Shell's Texas expansion will create the U.S.'s biggest oil refinery. |
The Motley Fool
September 26, 2007
Toby Shute |
At Last, the New Yamana Yamana, Meridian, and Northern Orion Resources are now one. The combined company has more inferred resources than any other miner in its mid-tier peer group. Investors, take note. |
The Motley Fool
September 26, 2007
Anders Bylund |
Wearing a Red Hat and Running Shoes Red Hat is setting itself up to benefit from the virtualization trend, focusing on scaling up operations in anticipation of a boost in orders. Investors, take note. |
The Motley Fool
September 26, 2007
Rich Duprey |
A Mouse Trap for KB Home KB Home's newly announced partnership with Disney to offer Disney-themed decor seems to show just how desperate the homebuilder is. |
The Motley Fool
September 26, 2007
Brian Orelli |
4 Platform Drugmakers to Watch Platform drugmakers have the potential to develop multiple drugs for a company. Let's take a look at four companies with good prospects: Abraxis BioScience... DURECT... Halozyme... Flamel Technologies... |
The Motley Fool
September 26, 2007
Dave Mock |
Won't Vonage Ask for the Check, Please? Internet telephony provider Vonage is facing stiff costs to remain in business after its loss in a patent-infringement lawsuit with Sprint Nextel. |
| <Older 26331-26340 Newer> Return to current articles. |
